R. Peter Lokken

1.6k total citations · 1 hit paper
48 papers, 1.1k citations indexed

About

R. Peter Lokken is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, R. Peter Lokken has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hepatology, 24 papers in Surgery and 19 papers in Epidemiology. Recurrent topics in R. Peter Lokken's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease and Transplantation (17 papers) and Liver Disease Diagnosis and Treatment (17 papers). R. Peter Lokken is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease and Transplantation (17 papers) and Liver Disease Diagnosis and Treatment (17 papers). R. Peter Lokken collaborates with scholars based in United States, Israel and Canada. R. Peter Lokken's co-authors include Christie Y. Jeon, Frank B. Hu, Rob M. van Dam, Ron C. Gaba, James T. Bui, Andrew J. Lipnik, Charles E. Ray, Stuart G. Silverman, Charles E. Ray and Gregory A. Wellenius and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

R. Peter Lokken

44 papers receiving 1.1k citations

Hit Papers

Physical Activity of Mode... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Peter Lokken United States 13 312 284 260 230 203 48 1.1k
Jee‐Jeon Yi South Korea 20 69 0.2× 150 0.5× 229 0.9× 108 0.5× 243 1.2× 46 1.0k
Emmanuel C. Gorospe United States 17 443 1.4× 107 0.4× 531 2.0× 141 0.6× 688 3.4× 86 1.6k
Peder Frederiksen Denmark 19 48 0.2× 235 0.8× 193 0.7× 258 1.1× 119 0.6× 67 1.1k
Vijayalakshmi Bhatia India 23 55 0.2× 111 0.4× 210 0.8× 462 2.0× 301 1.5× 75 1.9k
Atul Sharma Canada 20 47 0.2× 147 0.5× 188 0.7× 423 1.8× 369 1.8× 60 1.7k
Giovanni Mosconi Italy 18 90 0.3× 143 0.5× 71 0.3× 117 0.5× 226 1.1× 101 1.0k
Kishore Iyer United States 31 327 1.0× 496 1.7× 179 0.7× 130 0.6× 1.6k 7.8× 94 3.0k
Yuxiu Liu China 14 152 0.5× 45 0.2× 481 1.9× 90 0.4× 125 0.6× 37 1.0k
R. M. Francis United Kingdom 19 58 0.2× 180 0.6× 137 0.5× 97 0.4× 379 1.9× 51 1.9k
Barbara de Graaff Australia 16 60 0.2× 95 0.3× 174 0.7× 127 0.6× 133 0.7× 63 997

Countries citing papers authored by R. Peter Lokken

Since Specialization
Citations

This map shows the geographic impact of R. Peter Lokken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Peter Lokken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Peter Lokken more than expected).

Fields of papers citing papers by R. Peter Lokken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Peter Lokken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Peter Lokken. The network helps show where R. Peter Lokken may publish in the future.

Co-authorship network of co-authors of R. Peter Lokken

This figure shows the co-authorship network connecting the top 25 collaborators of R. Peter Lokken. A scholar is included among the top collaborators of R. Peter Lokken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Peter Lokken. R. Peter Lokken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ronald, James, et al.. (2024). Hepatobiliary Infection after Transjugular Intrahepatic Portosystemic Shunt Creation in Patients with Prior Biliary Intervention: A Multi-Institution Retrospective Study. Journal of Vascular and Interventional Radiology. 35(9). 1323–1331.e3. 1 indexed citations
2.
Wu, Xiao, Allison J. Kwong, Michael Heller, et al.. (2023). Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplant. Liver Transplantation. 30(2). 151–159. 1 indexed citations
3.
Wu, Xiao, et al.. (2023). Socioeconomic and Survival Analysis of Radioembolization in Patients with Intrahepatic Cholangiocarcinoma: A Propensity Score–Adjusted Study. Journal of Vascular and Interventional Radiology. 34(5). 815–823.e1. 2 indexed citations
4.
Wu, Xiao, R. Peter Lokken, & Neil Mehta. (2023). Optimal treatment for small HCC (<3 cm): Resection, liver transplantation, or locoregional therapy?. JHEP Reports. 5(8). 100781–100781. 4 indexed citations
5.
Elkhadragy, Lobna, et al.. (2022). Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model. Journal of Vascular and Interventional Radiology. 33(10). 1213–1221.e5. 1 indexed citations
6.
Kohlbrenner, Ryan, et al.. (2022). Large thrombosed portomesenteric venous aneurysm treated with pharmacomechanical thrombolysis combined with TIPS placement. CVIR Endovascular. 5(1). 11–11. 1 indexed citations
7.
Hills, Nancy K., et al.. (2021). Accuracy of Disclosed Financial Relationships between Radiologists and Industry at the 2018 RSNA Annual Meeting. Radiology. 300(2). 433–435. 3 indexed citations
8.
Gaba, Ron C., Lobna Elkhadragy, Herbert E. Whiteley, et al.. (2021). Conventional versus drug-eluting embolic transarterial chemoembolization with doxorubicin: comparative drug delivery, pharmacokinetics, and treatment response in a rabbit VX2 tumor model. Drug Delivery and Translational Research. 12(5). 1105–1117. 9 indexed citations
9.
Lokken, R. Peter, Robert K. Kerlan, Yifan Chen, et al.. (2021). Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma. American Journal of Roentgenology. 216(5). 1283–1290. 4 indexed citations
10.
Kohlbrenner, Ryan, K. Kolli, Nicholas Fidelman, et al.. (2020). Intermediate to Long-Term Clinical Outcomes of Percutaneous Cryoablation for Renal Masses. Journal of Vascular and Interventional Radiology. 31(8). 1242–1248. 10 indexed citations
11.
Huang, Yuhui, Benjamin V. Park, Yifan Chen, et al.. (2019). Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score–Matched Study. Journal of Vascular and Interventional Radiology. 30(9). 1317–1324. 6 indexed citations
12.
Huang, Yu-Hui, et al.. (2019). Development and Angiographic Use of the Rabbit VX2 Model for Liver Cancer. Journal of Visualized Experiments. 11 indexed citations
13.
Lokken, R. Peter, et al.. (2018). Does advanced chronic kidney disease impact transjugular intrahepatic portosystemic shunt efficacy and safety?. PubMed. 80(2). 243–248. 5 indexed citations
14.
Gaba, Ron C., et al.. (2018). Transhepatic Revision of Occluded Transjugular Intrahepatic Portosystemic Shunt Complicated by Endotipsitis. Seminars in Interventional Radiology. 35(5). 492–496. 6 indexed citations
15.
Lipnik, Andrew J., et al.. (2018). Gastric Varices Bleed at Lower Portosystemic Pressure Gradients than Esophageal Varices. Journal of Vascular and Interventional Radiology. 29(5). 636–641. 26 indexed citations
16.
Gaba, Ron C., R. Peter Lokken, Jack Zwanziger, et al.. (2018). Eight Years’ Experience With a Radiology-Sponsored Medical Student Research Fellowship Program. Journal of the American College of Radiology. 16(2). 224–227. 1 indexed citations
17.
Gaba, Ron C., et al.. (2017). Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging. Current Gastroenterology Reports. 19(11). 58–58. 2 indexed citations
18.
Hansmann, Jan, James T. Bui, R. Peter Lokken, et al.. (2017). Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 28(9). 1224–1231.e2. 53 indexed citations
19.
Fidelman, Nicholas, M.D. Miller, Michelle L. Johnson, et al.. (2016). Safety of yttrium-90 radioembolization for patients with history of biliary tract instrumentation: a multicenter study. Journal of Vascular and Interventional Radiology. 27(3). S6–S7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026